|
|
|
Insider
Information: |
Bentsur Ron |
Relationship: |
Chairman & CEO, Direct... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
4,188,470 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$52,464 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
4,188,470 |
|
|
Total
Value |
$52,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
Chief Executive Office... |
2015-04-06 |
777,209 |
|
0 |
Premium* |
|
XTL Biopharmaceuticals Ltd |
XTLBY |
CEO |
2007-08-21 |
20,101 |
|
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2020-06-10 |
0 |
|
0 |
Premium* |
|
Beyond Air Ord Shs |
XAIR |
Director |
2023-03-20 |
144,736 |
|
0 |
Premium* |
|
Nuvectis Pharma, Inc. |
NVCT |
Chairman & CEO, Direct... |
2024-05-14 |
3,246,424 |
2022-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
XAIR |
Beyond Air Ord Shs |
Director |
|
2021-01-02 |
4 |
S |
$5.89 |
$33,573 |
D/D |
(5,700) |
183,936 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-01-04 |
4 |
S |
$2.74 |
$16,467 |
D/D |
(6,010) |
497,036 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-06 |
4 |
AS |
$5.94 |
$36,777 |
D/D |
(6,192) |
255,596 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-19 |
4 |
AS |
$6.32 |
$41,266 |
D/D |
(6,533) |
202,129 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-14 |
4 |
AS |
$5.53 |
$36,932 |
D/D |
(6,680) |
217,653 |
0 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-03-17 |
4 |
B |
$7.63 |
$53,410 |
D/D |
7,000 |
2,821,459 |
3.23 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-08-10 |
4 |
B |
$3.05 |
$22,905 |
D/D |
7,500 |
359,281 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-14 |
4 |
B |
$5.88 |
$47,040 |
D/D |
8,000 |
2,814,459 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-10 |
4 |
B |
$6.34 |
$53,890 |
D/D |
8,500 |
2,806,459 |
2.81 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2015-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,285 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2017-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
27,285 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2020-08-07 |
4 |
AS |
$5.35 |
$54,657 |
D/D |
(10,222) |
245,374 |
0 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-05-12 |
4 |
B |
$14.88 |
$208,047 |
D/D |
12,245 |
2,957,704 |
3.23 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2018-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,158 |
40,443 |
0 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-08-18 |
4 |
B |
$8.58 |
$123,775 |
D/D |
14,426 |
3,002,409 |
3.23 |
- |
|
XTLBY |
XTL Biopharmaceuticals Lt... |
CEO |
|
2007-08-21 |
4 |
B |
$1.30 |
$19,863 |
D/D |
15,279 |
20,101 |
2.74 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2012-04-18 |
4 |
B |
$1.29 |
$24,773 |
D/D |
19,100 |
479,476 |
2.81 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-08-11 |
4 |
B |
$8.40 |
$165,220 |
D/D |
19,669 |
2,987,983 |
3.23 |
- |
|
NVCT |
Nuvectis Pharma, Inc. |
Chairman & CEO |
|
2022-02-07 |
4 |
B |
$3.93 |
$104,520 |
D/D |
20,000 |
2,797,959 |
2.81 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2018-02-16 |
4 |
OE |
$4.25 |
$99,531 |
D/D |
23,419 |
283,499 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2021-02-12 |
4 |
OE |
$4.25 |
$99,531 |
D/D |
23,419 |
205,855 |
0 |
- |
|
XAIR |
Beyond Air Ord Shs |
Director |
|
2021-02-12 |
4 |
S |
$6.36 |
$148,945 |
D/D |
(23,419) |
182,436 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2011-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
380,572 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
Chief Executive Officer |
|
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
503,046 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2019-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
65,443 |
0 |
- |
|
152 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|